GB0619891D0 - Pharmaceutical composition of risedronate - Google Patents

Pharmaceutical composition of risedronate

Info

Publication number
GB0619891D0
GB0619891D0 GBGB0619891.5A GB0619891A GB0619891D0 GB 0619891 D0 GB0619891 D0 GB 0619891D0 GB 0619891 A GB0619891 A GB 0619891A GB 0619891 D0 GB0619891 D0 GB 0619891D0
Authority
GB
United Kingdom
Prior art keywords
risedronate
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0619891.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Original Assignee
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo, Pliva Istrazivanje i Razvoj doo filed Critical Pliva Hrvatska doo
Priority to GBGB0619891.5A priority Critical patent/GB0619891D0/en
Publication of GB0619891D0 publication Critical patent/GB0619891D0/en
Priority to PCT/GB2007/003784 priority patent/WO2008040993A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0619891.5A 2006-10-07 2006-10-07 Pharmaceutical composition of risedronate Ceased GB0619891D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0619891.5A GB0619891D0 (en) 2006-10-07 2006-10-07 Pharmaceutical composition of risedronate
PCT/GB2007/003784 WO2008040993A1 (en) 2006-10-07 2007-10-05 Pharmaceutical formulation of risedronate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0619891.5A GB0619891D0 (en) 2006-10-07 2006-10-07 Pharmaceutical composition of risedronate

Publications (1)

Publication Number Publication Date
GB0619891D0 true GB0619891D0 (en) 2006-11-15

Family

ID=37454193

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0619891.5A Ceased GB0619891D0 (en) 2006-10-07 2006-10-07 Pharmaceutical composition of risedronate

Country Status (2)

Country Link
GB (1) GB0619891D0 (en)
WO (1) WO2008040993A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104721165B (en) * 2015-03-25 2017-07-07 河北仁合益康药业有限公司 A kind of risedronate sodium is coated tablet composition and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20023574A3 (en) * 2002-10-25 2004-04-14 Léčiva, A.S. New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyehtylidene-1,1-bisphosphonic acid
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
CN101198316A (en) * 2005-03-17 2008-06-11 伊兰制药国际有限公司 Nanoparticulate bisphosphonate compositions
GB0519891D0 (en) * 2005-09-30 2005-11-09 Pliva Hrvatska D O O Pharmaceutically acceptable salts and hydrates

Also Published As

Publication number Publication date
WO2008040993A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
IL268462A (en) Dosage forms of risedronate
ZA200900347B (en) Preparation of pharmaceutical compositions
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
EP2025337A4 (en) External pharmaceutical composition
EP2005959A4 (en) External pharmaceutical composition
PL2005958T3 (en) External pharmaceutical composition
HK1138732A1 (en) Pharmaceutical compositions
AP2920A (en) Anti-malarial pharmaceutical composition
IL193372A0 (en) Pharmaceutical composition comprising oseltamivir phosphate
ZA200810178B (en) Pharmaceutical compositions for sustained release of phenyephrine
GB0610322D0 (en) Novel pharmaceutical compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
EP2070919A4 (en) Spiroquinone compound and pharmaceutical composition
EP2114374A4 (en) Pharmaceutical compositions of entacapone
EP2124959A4 (en) Pharmaceutical composition
EP2114404A4 (en) Pharmaceutical compound and composition
GB0619891D0 (en) Pharmaceutical composition of risedronate
GB0600032D0 (en) Pharmaceutical composition
GB0612696D0 (en) Pharmaceutical composition
GB0617578D0 (en) Pharmaceutical composition
GB0617340D0 (en) Anti-malarial pharmaceutical composition
ZA200808030B (en) Pharmaceutical compositions
HU0600939D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)